As of April 16, 2025, Genprex (GNPX) has a market cap of $6.280 million USD. According to our data, Genprex is ranked No.8948 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $6.28 M |
-13.37%
|
Dec 31, 2024 | $7.25 M |
-90.74%
|
Dec 29, 2023 | $78.27 M |
-84.14%
|
Dec 30, 2022 | $0.49 B |
10.69%
|
Dec 31, 2021 | $0.45 B |
-68.43%
|
Dec 31, 2020 | $1.41 B |
1,196.87%
|
Dec 31, 2019 | $0.11 B |
-70.91%
|
Dec 31, 2018 | $0.37 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() Arbutus Biopharma
ABUS
|
$0.61 B |
-0.000 M
|
![]() USA
|
![]() Arrowhead Pharmaceuticals
ARWR
|
$1.77 B |
-0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Replimune
REPL
|
$0.59 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Vericel
VCEL
|
$2.11 B |
-0.000 M
|
![]() USA
|
Market Cap | = | GNPX Stock Price | * | GNPX Shares Outstanding |
= | $0.26 | * | 24.15 M | |
= | $6.28 M |